Mathematical Modeling and Simulation to Investigate the CNS Transport Characteristics of Nanoemulsion-Based Drug Delivery Following Intranasal Administration

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Pharmaceutical Research

• Publication date

  2019-03-28

• Fields of study

  Chemistry, Medicine, Mathematics

• Identifiers
  DOI 10.1007/s11095-019-2610-yPMID 30923914
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kaempferol‐loaded mucoadhesive nanoemulsion for intranasal administration reduces glioma growth in vitro

  2018cited by this paper
• Recent advances in carrier mediated nose‐to‐brain delivery of pharmaceutics

  2018cited by this paper
• Mechanism of intranasal drug delivery directly to the brain

  2018cited by this paper
• Parenteral nanoemulsions of risperidone for enhanced brain delivery in acute psychosis: Physicochemical and in vivo performances.

  2017cited by this paper
• Mathematical Modeling and Experimental Validation of Nanoemulsion-Based Drug Transport across Cellular Barriers

  2017cited by this paper
• Characterisation, in‐vitro and in‐vivo evaluation of valproic acid‐loaded nanoemulsion for improved brain bioavailability

  2017cited by this paper
• Progress in brain targeting drug delivery system by nasal route

  2017cited by this paper
• Quetiapine Nanoemulsion for Intranasal Drug Delivery: Evaluation of Brain-Targeting Efficiency

  2017cited by this paper
• Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation.

  2016cited by this paper
• Insights From an Integrated Physiologically Based Pharmacokinetic Model for Brain Penetration.

  2016cited by this paper
• Nanosized Drug Delivery Systems for Direct Nose to Brain Targeting: A Review.

  2016cited by this paper
• Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides

  2016cited by this paper
• Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration

  2015cited by this paper
• Nano-ropinirole for the management of Parkinsonism: blood–brain pharmacokinetics and carrier localization

  2015cited by this paper
• Comparative Biodistribution and Pharmacokinetic Analysis of Cyclosporine-A in the Brain upon Intranasal or Intravenous Administration in an Oil-in-Water Nanoemulsion Formulation.

  2015cited by this paper
• Emerging Insights for Translational Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Studies: Towards Prediction of Nose-to-Brain Transport in Humans

  2015cited by this paper
• Passive Diffusion Permeability of the BBB—Examples and SAR

  2015cited by this paper
• Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases

  2015cited by this paper
• Insights into direct nose to brain delivery: current status and future perspective

  2014cited by this paper
• Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting

  2014cited by this paper
• Quantitative analysis of drug delivery to the brain via nasal route.

  2014cited by this paper
• Nanoemulsions in Translational Research—Opportunities and Challenges in Targeted Cancer Therapy

  2014cited by this paper
• Nanotechnology for CNS delivery of bio-therapeutic agents

  2013cited by this paper
• Intranasal administration of milnacipran in rats: evaluation of the transport of drugs to the systemic circulation and central nervous system and the pharmacological effect.

  2011cited by this paper
• Systemic and Direct Nose-to-Brain Transport Pharmacokinetic Model for Remoxipride after Intravenous and Intranasal Administration

  2011cited by this paper
• Intranasal delivery to the central nervous system: mechanisms and experimental considerations.

  2010cited by this paper
• Nanoparticles for direct nose-to-brain delivery of drugs.

  2009cited by this paper
• Novel Vasoconstrictor Formulation to Enhance Intranasal Targeting of Neuropeptide Therapeutics to the Central Nervous System

  2009cited by this paper
• Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease

  2008cited by this paper
• Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting

  2008cited by this paper
• Intranasal nanoemulsion based brain targeting drug delivery system of risperidone.

  2008cited by this paper
• Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies

  2008cited by this paper
• Formulation and physiological factors influencing CNS delivery upon intranasal administration.

  2006cited by this paper
• Absorption Enhancers for Nasal Drug Delivery

  2003cited by this paper
• The distribution of local anesthetics into the CSF following intranasal administration

  1998cited by this paper

• Challenges and Opportunities for Incorporating Physiological Information into Pharmacokinetic Models of Intranasal Drug Delivery to the Brain: A Review of the Current Status and Future Trajectories.

  2025cites this paper
• Intranasal Drug Delivery Technology in the Treatment of Central Nervous System Diseases: Challenges, Advances, and Future Research Directions

  2025cites this paper
• Pharmacokinetic and Pharmacodynamic Insights of Bioactive Molecules Encapsulated in Liposomal Formulation

  2025cites this paper
• Pharmacokinetics of intranasal drugs, still a missed opportunity?

  2024cites this paper
• Study of digoxin concentrations using uncertain differential equations

  2024cites this paper
• Donepezil Brain and Blood Pharmacokinetic Modeling after Nasal Film and Oral Solution Administration in Mice

  2023cites this paper
• Optimization of Propofol Dose Estimated During Anesthesia Through Artificial Intelligence by Genetic Algorithm: Design and Clinical Assessment

  2022cites this paper
• Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.

  2021cites this paper
• Towards the Development of Delivery Systems of Bioactive Compounds With Eyes Set on Pharmacokinetics

  2021cites this paper
• Pharmacokinetics modeling in drug delivery

  2021cites this paper
• Quantitative and qualitative analysis of direct nose-to-brain drug delivery

  2021cites this paper
• Quality by Design tools reducing the gap from bench to bedside for nanomedicine.

  2021cites this paper
• Comparative Study of the Development and Characterization of Ecofriendly Oil and Water Nanoemulsions for Improving Antifungal Activity

  2021cites this paper
• The role of artificial intelligence in scaling nanomedicine toward broad clinical impact

  2020cites this paper
• Application of Pharmacokinetic-Pharmacodynamic Modeling in Drug Delivery: Development and Challenges

  2020cites this paper